#2 20p. Calculate the number of Influenza virus particles, PFU, in 1 ml of serum of an individual suffering of Influenza infection. You used 0.6mls of 1/4000 serum dilution to inoculate a monolayer of indicator cells on a petri dish. Two days later you enumerated 200 PFU on the tissue culture well
#3 60p. You have in your laboratory three different antisera specific for the Influenza virus:
Antiserum A, was identified previously with a Western blotting assay to bind specifically to a viral surface protein employed by the H1N1 virus to attach to human epethilial cells.
Antisera B is binding to a viral nucleoprotein of the same H1N1 virus while
Antisera C is binding specifically to a viral surface protein employed by the H5N1 virus to attach to human epethilial cells.
You performed a virus neutralization test similar to the one performed in laboratory #7. You may assume that you used the same volumes and serum dilution as in question #2
-Outline briefly the protocol (basic experimental groups) that would allow you to characterize the putative neutralizing properties of the three antisera
-Predict the number of Influenza PFUs caused by H1N1 virus employing antisera A, B and C under optimal conditions of virus and antibody concentrations
2) According to the question, 0.6 mL of 1/4000 dilution serum was plated & 200 PFU were counted.
So, in 0.6 mL of serum (without dilution) number of PFU = 200 x 4000 = 800,000
So, in 1 mL of serum number
of influenza virus particle = (800,000/0.6) PFU =
1,333,333
PFU
#2 20p. Calculate the number of Influenza virus particles, PFU, in 1 ml of serum of...
QUESTION 1 Although SARS-CoV-2 is currently a global health threat, how might we turn it into a tool for biotechnology? a. It could possibly be turned into a viral vector against lung cancers b. Its promoters might be used to express genes in lung cells c. Its surface proteins could be used for new epitope tags d. All of the above QUESTION 2 Which of the following are applications of molecular assembly described in this course? a. It can be...